The investment seeks to track the investment results of the Russell 1000 Consumer Staples RIC 22... Show more
The iShares U.S. Consumer Staples ETF seeks to track an index composed of U.S. equities in the consumer staples sector, providing diversified, low-cost access to producers of food, beverages, and household goods. The fund is structured as a passively managed, index-based ETF that generally invests at least 80% of its assets in the components of its underlying benchmark, the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index.
With roughly 58 holdings and an expense ratio of approximately 0.38%, IYK offers broad sector exposure at a competitive cost. The portfolio is dominated by household names: Procter & Gamble (PG), Coca-Cola (KO), Philip Morris International (PM), and PepsiCo (PEP) rank among the largest positions, followed by Altria (MO), CVS Health (CVS), McKesson (MCK), Mondelez (MDLZ), Colgate-Palmolive (CL), and Monster Beverage (MNST). From a sector perspective, food, beverage, and tobacco accounts for roughly 58% of assets, household and personal products about 21%, health care equipment and services roughly 11% to 13%, and consumer staples distribution and retail near 6% to 7%.
Consumer staples occupy a structurally defensive position within equity markets because demand for everyday goods such as food, beverages, and household products tends to hold up even when economic growth slows. That resilience has historically translated into lower volatility: IYK's equity beta is well below 1.0, meaning the fund has tended to move less than the broader market in both directions.
The sector's investment case rests on a combination of pricing power, brand loyalty, and dependable free cash flow that supports dividends and share buybacks. At the same time, staples companies face a mature competitive landscape in which volume growth is often modest, making revenue gains heavily dependent on price increases and product mix. The tobacco complex within the portfolio introduces additional regulatory and litigation considerations, while rising input costs and shifting consumer preferences toward value-oriented and private-label products remain persistent headwinds.
IYK has delivered a measured, gradual advance in recent months rather than sharp momentum. Over the last 30 days, the fund has risen roughly 7%, while over the last quarter it is up approximately 5% — a steady but unspectacular climb consistent with its defensive profile. This behavior reflects rotation into lower-volatility, dividend-paying equities as investors weigh the trajectory of interest rates and the durability of consumer spending.
The performance has been underpinned by the fund's largest holdings, several of which carry meaningful weight in the index and exert outsized influence on returns. Strength in mega-cap staples leaders such as Procter & Gamble and Coca-Cola, alongside steady contributions from Philip Morris International and PepsiCo, has supported the ETF's recent advance. Because the top ten positions account for roughly two-thirds of assets, IYK's performance is closely tied to the earnings and guidance of a relatively small group of multinational consumer companies.
Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. It is designed to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening, while helping users compare positioning across industries and themes. For investors evaluating consumer staples exposure or seeking to identify adjacent opportunities, the AI Screener offers a structured, data-driven way to refine watchlists and monitor evolving market conditions.
Looking across 2026, several structural factors are likely to shape IYK's trajectory. The path of interest rates remains central: as a low-beta, dividend-heavy fund, staples often become more attractive relative to fixed income when yields stabilize or decline, and less compelling when rates rise. Inflation trends and their impact on input costs and consumer pricing power will likewise influence margins across food, beverage, and household product makers.
Earnings cycles among the fund's largest holdings matter disproportionately given portfolio concentration, so investors should monitor volume growth, gross margin direction, and foreign-exchange effects at the major multinational constituents. Regulatory and litigation developments in the tobacco segment, along with any policy shifts affecting health care distribution and retail names in the portfolio, represent additional watchpoints. Finally, capital flows into and out of defensive ETFs and competition from lower-cost or alternatively structured staples funds may affect both fund assets and relative performance. None of these factors constitutes a forecast of future returns, but together they define the landscape most likely to influence IYK over the months ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day RSI Oscillator for IYK moved out of overbought territory on October 23, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 instances where the indicator moved out of the overbought zone. In 31 of the 38 cases the stock moved lower in the days that followed. This puts the odds of a move down at 82%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IYK as a result. In 61 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for IYK turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 30 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
IYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +1.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 266 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 229 of 305 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows